Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/19328| Title: | Comparative effectiveness of cardiovascular outcomes in new users of sodium-glucose cotransporter-2 inhibitors: SGLT2 inhibitors in the real world. | Austin Authors: | MacIsaac, Richard J;Ekinci, Elif I | Affiliation: | Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia Department of Endocrinology & Diabetes, St Vincent's Hospital, Melbourne, Victoria, Australia Department of Medicine, St Vincent's Hospital, University of Melbourne, Victoria, Australia Endocrine Centre, Austin Health, Heidelberg, Victoria, Australia |
Issue Date: | Dec-2017 | Publication information: | Annals of translational medicine 2017; 5(23): 474 | URI: | http://ahro.austin.org.au/austinjspui/handle/1/19328 | DOI: | 10.21037/atm.2017.10.11 | ORCID: | 0000-0003-2372-395X | Journal: | Annals of translational medicine | PubMed URL: | 29285507 | ISSN: | 2305-5839 | Type: | Journal Article |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.